Castle Biosciences says Greater Phoenix’s bioscience network helped transform it from a startup into a scaled diagnostics company. The growth is showing in resu

Castle Biosciences says Greater Phoenix’s bioscience network helped transform it from a startup into a scaled diagnostics company. The growth is showing in results: Q2 2026 revenue reached $103.5 million as core test volume rose 32% from a year earlier.